<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>immunotherapy Archives &#8211; J-Wire</title>
	<atom:link href="https://www.jwire.com.au/tag/immunotherapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.jwire.com.au/tag/immunotherapy/</link>
	<description>Australia, NZ and worldwide Jewish news that matters</description>
	<lastBuildDate>Thu, 11 Aug 2022 04:24:54 +0000</lastBuildDate>
	<language>en-AU</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://i0.wp.com/www.jwire.com.au/wp-content/uploads/cropped-Jwirelogocleangoog.jpg?fit=32%2C32&#038;ssl=1</url>
	<title>immunotherapy Archives &#8211; J-Wire</title>
	<link>https://www.jwire.com.au/tag/immunotherapy/</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">6446428</site>	<item>
		<title>Israeli-led research develops molecule that makes immunotherapy available to all cancer patients</title>
		<link>https://www.jwire.com.au/israeli-led-research-develops-molecule-that-makes-immunotherapy-available-to-all-cancer-patients/</link>
					<comments>https://www.jwire.com.au/israeli-led-research-develops-molecule-that-makes-immunotherapy-available-to-all-cancer-patients/#respond</comments>
		
		<dc:creator><![CDATA[Aryeh Savir - TPS]]></dc:creator>
		<pubDate>Tue, 09 Aug 2022 06:08:54 +0000</pubDate>
				<category><![CDATA[Featured Articles]]></category>
		<category><![CDATA[cancer patients]]></category>
		<category><![CDATA[immunotherapy]]></category>
		<category><![CDATA[Israeli led research]]></category>
		<guid isPermaLink="false">https://www.jwire.com.au/?p=139596</guid>

					<description><![CDATA[<p>Researchers at Tel Aviv University and the University of Lisbon have jointly identified and synthesised a small molecule that could be a more accessible and effective alternative to an antibody that is successfully used to treat a range of cancers. Behind the groundbreaking development is an international team of researchers led by Prof. Ronit Sachi-Fainaro, [&#8230;]</p>
<p>The post <a href="https://www.jwire.com.au/israeli-led-research-develops-molecule-that-makes-immunotherapy-available-to-all-cancer-patients/">Israeli-led research develops molecule that makes immunotherapy available to all cancer patients</a> appeared first on <a href="https://www.jwire.com.au">J-Wire</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.jwire.com.au/israeli-led-research-develops-molecule-that-makes-immunotherapy-available-to-all-cancer-patients/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">139596</post-id>	</item>
	</channel>
</rss>

<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/?utm_source=w3tc&utm_medium=footer_comment&utm_campaign=free_plugin

Page Caching using Disk: Enhanced 

Served from: www.jwire.com.au @ 2026-06-21 10:24:55 by W3 Total Cache
-->